Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price
Global COVID-19 Saliva Screening Test Potential Market Report 2024

COVID-19 Saliva Screening Test Potential Global Market Report 2024 – By Location (Travel Stations, Sports Arenas, Entertainment Venues, Corporate Campus Environments, Universities And Colleges, Factories, Other Locations), By Technology (Fluorescence-Labelled Antigen, RT-PCR, CRISPR-Cas9), By Mode of Testing (Centralized Testing, Decentralized Testing) – Market Size, Trends, And Global Forecast 2024-2033

COVID-19 Saliva Screening Test Potential Global Market Report 2024

Starting Price : $5000.00 | Pages : 175 | Published : July 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
COVID-19 Saliva Screening Test Potential Global Market Report 2024

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

COVID-19 Saliva Screening Test Potential Market Definition And Segments

The COVID-19 saliva screening test potential refers to the potential advantages and capabilities that saliva-based tests for detecting SARS-CoV-2, the virus that causes COVID-19, could offer compared to traditional methods such as nasopharyngeal or oropharyngeal swab tests. Their potential lies in improving testing accessibility, patient acceptance, cost-effectiveness, and safety while enabling new testing strategies and approaches to manage the COVID-19 pandemic better.

The main locations of COVID-19 saliva screening test potential are travel stations, sports arenas, entertainment venues, corporate campus environments, universities and colleges, factories, and other locations. Travel stations are designated areas in transportation hubs where individuals can undergo COVID-19 saliva screening tests before embarking on journeys. The various technologies used are fluorescence-labeled antigen, rt-PCR, and CRISPR-Cas9 and various modes of testing include centralized testing and decentralized testing.

The COVID-19 saliva screening test potential market covered in this report is segmented –

1) By Location: Travel Stations, Sports Arenas, Entertainment Venues, Corporate Campus Environments, Universities And Colleges, Factories, Other Locations

2) By Technology: Fluorescence-Labelled Antigen, RT-PCR, CRISPR-Cas9

3) By Mode of Testing: Centralized Testing, Decentralized Testing

The COVID-19 saliva screening test potential market size has grown strongly in recent years. It will grow from $3.57 billion in 2023 to $3.90 billion in 2024 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to the potential for home testing, unprecedented need for diagnostic testing, rise in public awareness, and research and development investment.

The COVID-19 saliva screening test potential market size is expected to see strong growth in the next few years. It will grow to $5.64 billion in 2028 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to integration with screening programs, regulatory support, growing demand for speedy, point-of-care COVID-19 tests, increasing population, and the rise of e-commerce. Major trends in the forecast period include increased adoption in non-healthcare settings, integration with digital health platforms, emergence of next-generation technologies, technological advancements, and strategic partnerships.

The Role Of Increasing Healthcare Expenditure In Driving The Growth Of The COVID-19 Saliva Screening Test Market

The increasing healthcare expenditure is expected to propel the growth of the COVID-19 saliva screening test potential market going forward. Healthcare expenditure is the entire amount spent on healthcare-related goods and services, including prescription drugs, hospital stays, doctor visits, medical equipment, and public health campaigns. The healthcare expenditure is increasing due to several factors, such as minimally invasive surgeries, cutting-edge diagnostic tools, increase in research and development for new drugs, utilization of healthcare services, and specialty medications. The higher healthcare expenditure can provide the necessary resources and support to leverage the full potential of COVID-19 saliva screening tests, contributing to more effective pandemic management and better public health outcomes. For instance, in May 2023, according to the Office for National Statistics, a UK-based statistics authority, the UK's healthcare expenditure grew by 9.7% in real terms and 9.4% in nominal terms. The overall amount spent on healthcare in the UK in 2021 was $367.25 billion (£280.7 billion), while the total amount spent on pharmaceuticals was $51.84 billion (£39.6 billion). Further, spending on preventative care more than quadrupled to $45.93 billion (£35.1 billion) in 2021 compared to the previous year. Therefore, the increasing healthcare expenditure is driving the growth of the COVID-19 saliva screening test potential market.

Major companies operating in the COVID-19 saliva screening test potential market are Roche Diagnostics Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Becton Dickinson and Company, Danaher Corporation, University of North Carolina at Chapel Hill, Hologic Inc., Beaumont Health, PerkinElmer Inc., Quidel Corporation, University of Illinois at Urbana-Champaign, Cepheid, Seegene Inc., ARUP Laboratories, Vatic Health Limited, Ambry Genetics Corporation, LumiraDx Ltd., Yale School of Public Health, Gravity Diagnostics, Psomagen Inc., Fluidigm Corporation, Phosphorus Diagnostics LLC, DxTerity Diagnostics Inc., University of Notre Dame, MOgene, FLuroTech Ltd.

Innovative Technologies And Advanced Laboratory Techniques Driving Growth In The COVID-19 Saliva Screening Test Market

Major companies operating in the COVID-19 saliva screening test potential market are focused on developing innovative programs, such as COVID-19 saliva testing programs, to expand their product offerings and reach a broader customer base. A COVID-19 saliva testing program is an initiative or system implemented to test for SARS-CoV-2 (the virus that causes COVID-19) using saliva samples rather than more invasive nasopharyngeal or nasal swab samples. For instance, in April 2021, Mount Sinai Health System, a US-based healthcare network, launched the Mount Sinai COVID-19 PCR Saliva Testing program to provide quick, noninvasive, and precise testing. This testing program is designed to provide quick and accurate results, enabling individuals to return to in-person work settings and leisure activities confidently. The program's scalability is noteworthy, with plans to process up to 100,000 daily tests, ensuring widespread testing availability. Its success is further highlighted by the ability to report results within 24 hours for most tests, demonstrating efficiency and rapid response capabilities. The program aims to facilitate the safe return to in-person learning and activities by offering child-friendly and comfortable testing options. This initiative emphasizes the importance of testing in controlling the spread of COVID-19 and supports the community's well-being during the reopening phase.

Hologic Inc. Expands Diagnostics Market Presence With Acquisition Of Mobidiag Oy

In June 2021, Hologic Inc., a US-based health technology company, acquired Mobidiag Oy for an undisclosed amount. This strategic move enables Hologic to expand its presence in the diagnostics market by leveraging Mobidiag’s innovative near-patient molecular diagnostic instruments and tests. Mobidiag Oy is a Finland-based company that specializes in COVID-19 saliva screening tests.

North America was the largest region in the COVID-19 saliva screening test potential market in 2023. The regions covered in the COVID-19 saliva screening test potential market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the COVID-19 saliva screening test potential market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The COVID-19 saliva screening test potential market consist revenues earned by entities by providing services such as sample collection services, laboratory testing services, diagnostic reporting services, and screening and monitoring services. The market value includes the value of related goods sold by the service provider or included within the service offering. The COVID-19 saliva screening test potential market also consists of sales of saliva collection kits, rapid saliva testing kits, laboratory testing supplies, and automated sample processing systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The COVID-19 saliva screening test potential market research report is one of a series of new reports from The Business Research Company that provides COVID-19 saliva screening test potential market statistics, including COVID-19 saliva screening test potential industry global market size, regional shares, competitors with a COVID-19 saliva screening test potential market share, detailed COVID-19 saliva screening test potential market segments, market trends, and opportunities, and any further data you may need to thrive in the COVID-19 saliva screening test potential industry. This COVID-19 saliva screening test potential market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

COVID-19 Saliva Screening Test Potential Market Report Scope
Report AttributeDetails
Market Size Value In 2024 $3.9 billion
Revenue Forecast In 2033 $5.64 billion
Growth Rate CAGR of 9.6% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Location: Travel Stations, Sports Arenas, Entertainment Venues, Corporate Campus Environments, Universities And Colleges, Factories, Other Locations
2) By Technology: Fluorescence-Labelled Antigen, RT-PCR, CRISPR-Cas9
3) By Mode of Testing: Centralized Testing, Decentralized Testing
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Additional countries that can be covered in the report for an additional fee: Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Roche Diagnostics Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Becton Dickinson and Company, Danaher Corporation, University of North Carolina at Chapel Hill, Hologic Inc., Beaumont Health, PerkinElmer Inc., Quidel Corporation, University of Illinois at Urbana-Champaign, Cepheid, Seegene Inc., ARUP Laboratories, Vatic Health Limited, Ambry Genetics Corporation, LumiraDx Ltd., Yale School of Public Health, Gravity Diagnostics, Psomagen Inc., Fluidigm Corporation, Phosphorus Diagnostics LLC, DxTerity Diagnostics Inc., University of Notre Dame, MOgene, FLuroTech Ltd.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. COVID-19 Saliva Screening Test Potential Market Characteristics

    3. COVID-19 Saliva Screening Test Potential Market Trends And Strategies

    4. COVID-19 Saliva Screening Test Potential Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On The Market

    4.2. Ukraine-Russia War Impact On The Market

    4.3. COVID-19 Impact On The Market

    5. Global COVID-19 Saliva Screening Test Potential Market Size and Growth

    5.1. Global COVID-19 Saliva Screening Test Potential Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global COVID-19 Saliva Screening Test Potential Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global COVID-19 Saliva Screening Test Potential Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. COVID-19 Saliva Screening Test Potential Market Segmentation

    6.1. Global COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Travel Stations

    Sports Arenas

    Entertainment Venues

    Corporate Campus Environments

    Universities And Colleges

    Factories

    Other Locations

    6.2. Global COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Fluorescence-Labelled Antigen

    RT-PCR

    CRISPR-Cas9

    6.3. Global COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Centralized Testing

    Decentralized Testing

    7. COVID-19 Saliva Screening Test Potential Market Regional And Country Analysis

    7.1. Global COVID-19 Saliva Screening Test Potential Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global COVID-19 Saliva Screening Test Potential Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific COVID-19 Saliva Screening Test Potential Market

    8.1. Asia-Pacific COVID-19 Saliva Screening Test Potential Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China COVID-19 Saliva Screening Test Potential Market

    9.1. China COVID-19 Saliva Screening Test Potential Market Overview

    9.2. China COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India COVID-19 Saliva Screening Test Potential Market

    10.1. India COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan COVID-19 Saliva Screening Test Potential Market

    11.1. Japan COVID-19 Saliva Screening Test Potential Market Overview

    11.2. Japan COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia COVID-19 Saliva Screening Test Potential Market

    12.1. Australia COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia COVID-19 Saliva Screening Test Potential Market

    13.1. Indonesia COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea COVID-19 Saliva Screening Test Potential Market

    14.1. South Korea COVID-19 Saliva Screening Test Potential Market Overview

    14.2. South Korea COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe COVID-19 Saliva Screening Test Potential Market

    15.1. Western Europe COVID-19 Saliva Screening Test Potential Market Overview

    15.2. Western Europe COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK COVID-19 Saliva Screening Test Potential Market

    16.1. UK COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany COVID-19 Saliva Screening Test Potential Market

    17.1. Germany COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France COVID-19 Saliva Screening Test Potential Market

    18.1. France COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.2. France COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.3. France COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy COVID-19 Saliva Screening Test Potential Market

    19.1. Italy COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.2. Italy COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.3. Italy COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain COVID-19 Saliva Screening Test Potential Market

    20.1. Spain COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.2. Spain COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.3. Spain COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe COVID-19 Saliva Screening Test Potential Market

    21.1. Eastern Europe COVID-19 Saliva Screening Test Potential Market Overview

    21.2. Eastern Europe COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia COVID-19 Saliva Screening Test Potential Market

    22.1. Russia COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America COVID-19 Saliva Screening Test Potential Market

    23.1. North America COVID-19 Saliva Screening Test Potential Market Overview

    23.2. North America COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA COVID-19 Saliva Screening Test Potential Market

    24.1. USA COVID-19 Saliva Screening Test Potential Market Overview

    24.2. USA COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada COVID-19 Saliva Screening Test Potential Market

    25.1. Canada COVID-19 Saliva Screening Test Potential Market Overview

    25.2. Canada COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America COVID-19 Saliva Screening Test Potential Market

    26.1. South America COVID-19 Saliva Screening Test Potential Market Overview

    26.2. South America COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil COVID-19 Saliva Screening Test Potential Market

    27.1. Brazil COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East COVID-19 Saliva Screening Test Potential Market

    28.1. Middle East COVID-19 Saliva Screening Test Potential Market Overview

    28.2. Middle East COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa COVID-19 Saliva Screening Test Potential Market

    29.1. Africa COVID-19 Saliva Screening Test Potential Market Overview

    29.2. Africa COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. COVID-19 Saliva Screening Test Potential Market Competitive Landscape And Company Profiles

    30.1. COVID-19 Saliva Screening Test Potential Market Competitive Landscape

    30.2. COVID-19 Saliva Screening Test Potential Market Company Profiles

    30.2.1. Roche Diagnostics Corporation

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Thermo Fisher Scientific Inc.

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Abbott Laboratories

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Becton Dickinson and Company

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. Danaher Corporation

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. COVID-19 Saliva Screening Test Potential Market Other Major And Innovative Companies

    31.1. University of North Carolina at Chapel Hill

    31.2. Hologic Inc.

    31.3. Beaumont Health

    31.4. PerkinElmer Inc.

    31.5. Quidel Corporation

    31.6. University of Illinois at Urbana-Champaign

    31.7. Cepheid

    31.8. Seegene Inc.

    31.9. ARUP Laboratories

    31.10. Vatic Health Limited

    31.11. Ambry Genetics Corporation

    31.12. LumiraDx Ltd.

    31.13. Yale School of Public Health

    31.14. Gravity Diagnostics

    31.15. Psomagen Inc.

    32. Global COVID-19 Saliva Screening Test Potential Market Competitive Benchmarking

    33. Global COVID-19 Saliva Screening Test Potential Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The COVID-19 Saliva Screening Test Potential Market

    35. COVID-19 Saliva Screening Test Potential Market Future Outlook and Potential Analysis

    35.1 COVID-19 Saliva Screening Test Potential Market In 2028 - Countries Offering Most New Opportunities

    35.2 COVID-19 Saliva Screening Test Potential Market In 2028 - Segments Offering Most New Opportunities

    35.3 COVID-19 Saliva Screening Test Potential Market In 2028 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global COVID-19 Saliva Screening Test Potential Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global COVID-19 Saliva Screening Test Potential Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Asia-Pacific, COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: China, COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: India, COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: Japan, COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Australia, COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Indonesia, COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: South Korea, COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: Western Europe, COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: UK, COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: Germany, COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: France, COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: Italy, COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Spain, COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Eastern Europe, COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Russia, COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: North America, COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: USA, COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: Canada, COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: South America, COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: Brazil, COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Middle East, COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Africa, COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Roche Diagnostics Corporation Financial Performance
  • Table 75: Thermo Fisher Scientific Inc. Financial Performance
  • Table 76: Abbott Laboratories Financial Performance
  • Table 77: Becton Dickinson and Company Financial Performance
  • Table 78: Danaher Corporation Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global COVID-19 Saliva Screening Test Potential Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global COVID-19 Saliva Screening Test Potential Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Asia-Pacific, COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: China, COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: India, COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: Japan, COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Australia, COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Indonesia, COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: South Korea, COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: Western Europe, COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: UK, COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: Germany, COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: France, COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: Italy, COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Spain, COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Eastern Europe, COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Russia, COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: North America, COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: USA, COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: Canada, COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: South America, COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: Brazil, COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Middle East, COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Africa, COVID-19 Saliva Screening Test Potential Market, Segmentation By Location, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, COVID-19 Saliva Screening Test Potential Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, COVID-19 Saliva Screening Test Potential Market, Segmentation By Mode Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Roche Diagnostics Corporation Financial Performance
  • Figure 75: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 76: Abbott Laboratories Financial Performance
  • Figure 77: Becton Dickinson and Company Financial Performance
  • Figure 78: Danaher Corporation Financial Performance
Forecasting Till 2030: Opportunities And Strategies In The Global Value Based Care Payment Market – Includes Value Based Care Payment Market Analysis
Read More
How Will The Nuclear Medicine Market Grow In 2022?
Read More
What Is The Pediatric Imaging Market Overview In 2022?
Read More
Latest Healthcare Technology Management Market Growth Study 2022-2026 By The Business Research Company
Read More
The Business Research Company offers the hospital acquired infection control market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the multiplex assays market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the healthcare it consulting market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth
Read More
Drug Screening Global Market Report 2024 – By Products (Rapid Testing Devices, Consumables, Other Products), By Sample Type (Oral Fluid Sample, Hair Sample, Urine Sample, Breath Sample, Other Sample Types), By End User (Drug Testing Laboratories, Workplaces, Criminal Justice and Law Enforcement Agencies, Hospitals, Drug Treatment Centers, Individual Users, Pain Management Centers, Schools and Colleges) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Security Screening Global Market Report 2024 – By Type (X-Ray System, Metal Detectors, Explosive Detectors, Biometric System, Other Types), By Application (Mail And Parcel, Baggage Scanning, Cargo And Vehicle Inspection, Explosives And Narcotics), By End-User (Government Buildings, Airports, Educational Institutes, Public Places, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Employment Screening Services Global Market Report 2024 – By Services (Background Screening, Verification, Driver Management, Medical And Drug Testing), By Verification (Qualification, Employment History Verification, Reference, Other Verifications), By Background Screening (Credit Check, Criminal Record), By Application (Healthcare, IT/Technology/Media, Financial Services, Staffing, Retail, Industrial, Travel And Hospitality, Government And Education, Transportation, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Carrier Screening Global Market Report 2024 – By Type (Expanded Carrier Screening, Targeted Disease Carrier Screening ), By Medical Condition (Pulmonary Conditions, Hematological Conditions, Neurological Conditions, Other Medical Conditions ), By Technology (DNA Sequencing, Polymerase Chain Reaction, Microarrays, Other Technologies ), By End User (Hospitals, Reference Laboratories, Physician Offices and Clinics, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Blood Screening Global Market Report 2024 – By Product (Reagents and Kits, Instruments, Software and Services), By Technology (Nucleic Acid Testing, Enzyme-Linked Immunosorbent Assay (ELISA), Rapid Tests, Western Blot Assays, Next-Generation Sequencing (NGS)), By End User (Blood Banks, Diagnostic Centers and Pathology Labs, Hospitals, Clinics, Ambulatory Surgical Centers (ASCs)) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Crushing, Screening, And Mineral Processing Equipment Global Market Report 2024 – By Type (Crushing And Screening Equipment, Mineral Processing Equipment), By Mobility (Stationary, Portable, Mobile), By Application (Construction And Plant Modification, Mining, Foundries And Smelters, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Airport Baggage Screening Systems Global Market Report 2024 – By Product Type (Advanced Imaging Systems, Computed Tomography Systems, Explosive Detection Systems, X-Ray Systems), By Baggage Type (Hold Baggage, Cabin Baggage), By Application (Civil Airport, Commercial Airport) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Cellular Health Screening Global Market Report 2024 – By Test Type (Single Test Panels, Telomere Tests, Oxidative Stress Tests, Inflammation Tests, Heavy Metals Tests, Multi-test Panels), By Sample Type (Blood, Saliva, Serum, Urine), By Collection Site (Home, Office, Hospital, Diagnostic Labs) – Market Size, Trends, And Global Forecast 2024-2033
View Report

Frequently Asked Questions

What is the definition of the covid-19 saliva screening test potential market?

The COVID-19 saliva screening test potential refers to the potential advantages and capabilities that saliva-based tests for detecting SARS-CoV-2, the virus that causes COVID-19, could offer compared to traditional methods such as nasopharyngeal or oropharyngeal swab tests. Their potential lies in improving testing accessibility, patient acceptance, cost-effectiveness, and safety while enabling new testing strategies and approaches to manage the COVID-19 pandemic better. For further insights on the covid-19 saliva screening test potential market, request a sample here

How will the covid-19 saliva screening test potential market drivers and restraints affect the covid-19 saliva screening test potential market dynamics? What forces will shape the covid-19 saliva screening test potential industry going forward?

The covid-19 saliva screening test potential market major growth driver - The Role Of Increasing Healthcare Expenditure In Driving The Growth Of The COVID-19 Saliva Screening Test Market. For further insights on the covid-19 saliva screening test potential market, request a sample here

What is the forecast market size or the forecast market value of the covid-19 saliva screening test potential market?

The COVID-19 saliva screening test potential market size has grown strongly in recent years. It will grow from $3.57 billion in 2023 to $3.90 billion in 2024 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to the potential for home testing, unprecedented need for diagnostic testing, rise in public awareness, and research and development investment. The COVID-19 saliva screening test potential market size is expected to see strong growth in the next few years. It will grow to $5.64 billion in 2028 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to integration with screening programs, regulatory support, growing demand for speedy, point-of-care COVID-19 tests, increasing population, and the rise of e-commerce. Major trends in the forecast period include increased adoption in non-healthcare settings, integration with digital health platforms, emergence of next-generation technologies, technological advancements, and strategic partnerships. For further insights on the covid-19 saliva screening test potential market, request a sample here

How is the covid-19 saliva screening test potential market segmented?

The covid-19 saliva screening test potential market is segmented
1) By Location: Travel Stations, Sports Arenas, Entertainment Venues, Corporate Campus Environments, Universities And Colleges, Factories, Other Locations
2) By Technology: Fluorescence-Labelled Antigen, RT-PCR, CRISPR-Cas9
3) By Mode of Testing: Centralized Testing, Decentralized TestingFor further insights on the covid-19 saliva screening test potential market, request a sample here

Which region has the largest share of the covid-19 saliva screening test potential market? What are the other regions covered in the report?

North America was the largest region in the COVID-19 saliva screening test potential market in 2023. The regions covered in the COVID-19 saliva screening test potential market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the covid-19 saliva screening test potential market, request a sample here.

Who are the major players in the covid-19 saliva screening test potential market?

Major companies operating in the COVID-19 saliva screening test potential market are Roche Diagnostics Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Becton Dickinson and Company, Danaher Corporation, University of North Carolina at Chapel Hill, Hologic Inc., Beaumont Health, PerkinElmer Inc., Quidel Corporation, University of Illinois at Urbana-Champaign, Cepheid, Seegene Inc., ARUP Laboratories, Vatic Health Limited, Ambry Genetics Corporation, LumiraDx Ltd., Yale School of Public Health, Gravity Diagnostics, Psomagen Inc., Fluidigm Corporation, Phosphorus Diagnostics LLC, DxTerity Diagnostics Inc., University of Notre Dame, MOgene, FLuroTech Ltd. For further insights on the covid-19 saliva screening test potential market, request a sample here.

What are the key trends in the covid-19 saliva screening test potential market?

Major trend in the covid-19 saliva screening test potential market - Innovative Technologies And Advanced Laboratory Techniques Driving Growth In The COVID-19 Saliva Screening Test Market. For further insights on the covid-19 saliva screening test potenti request a sample here.

What are the major opportunities in the covid-19 saliva screening test potential market? What are the strategies for the covid-19 saliva screening test potential market?

For detailed insights on the major opportunities and strategies in the covid-19 saliva screening test potential market, request a sample here.

How does the covid-19 saliva screening test potential market relate to the overall economy and other similar markets?

For detailed insights on covid-19 saliva screening test potential market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the covid-19 saliva screening test potential industry?

For detailed insights on the mergers and acquisitions in the covid-19 saliva screening test potential industry, request a sample here.

What are the key dynamics influencing the covid-19 saliva screening test potential market growth? SWOT analysis of the covid-19 saliva screening test potential market.

For detailed insights on the key dynamics influencing the covid-19 saliva screening test potential market growth and SWOT analysis of the covid-19 saliva screening test potential industry, request a sample here.